Healing ALS Registry (HAROS) for people with ALS, MND, and PLS
Official title: Healing ALS Registry Observational Study (HAROS)
Run by Healing Advocates Registry and Ministry · NCT07233148 · Data updated 2026-11-12
This fully remote registry asks people with ALS, MND, or PLS to enter monthly health, treatment, and lifestyle information to try to see which therapies and education relate to better physical outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 110 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Healing Advocates Registry and Ministry Academic / other |
| Locations | 1 site (Park City, Utah) |
| Status | Recruiting |
| Started | January 26, 2026 |
| Main results expected | February 5, 2036 |
| Study ends | March 31, 2036 |
| Registry record updated | June 24, 2026 |
| Trial ID | NCT07233148 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults diagnosed with ALS, MND, or PLS (preferably neurologist-confirmed) who can reliably complete monthly online data entry and are willing to report treatments and outcomes; active smokers are excluded.
✕Probably not a fit
People who smoke, cannot complete regular online entries, or are seeking access to experimental drug treatments are unlikely to receive direct benefit from this observational registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
HAROS is a prospective, fully remote observational registry enrolling at least 1,000 people diagnosed with ALS, MND, or PLS who will complete monthly online entries including ALSFRS‑R scores, symptoms, medications, supplements, diets, therapies, and hours of self‑study or education. The study will correlate these longitudinal patient-reported data with physical outcomes to identify patterns linked with slower progression or improved function. Investigators will analyze conventional and integrative medicine approaches and educational engagement to explore associations with clinical trajectories. Data will be contributed by participants in the U.S. and other countries and analyzed to generate hypotheses for future controlled research.
Why it matters
Potential benefit: If successful, the registry could highlight treatments, behaviors, or education programs associated with better function or slower progression and inform care choices and future trials.
How similar studies have gone: A small 45-patient retrospective registry analysis reported better-than-predicted outcomes, but large prospective evidence supporting integrative approaches in ALS is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with ALS, MND or PLS Exclusion Criteria: * Smokers
Where it's running
-
Virtual
Park City, Utah, United States Recruiting
Study contacts
- Principal investigator: William L Cowden, MD — Chair of Scientific Board of Academy of Comprehensive Integrative Medicine, Co-chair of Medical Advisory Team of Healing ALS
- Study coordinator: Healing ALS Study Administrator
- Email: Study@HealingALS.org
- Phone: 1-973-714-4621
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Electrical stimulation to reduce facial pain and improve jaw movement and chewing in people with motor neuron disease
This trial will try one 30-minute session of non-invasive facial electrical stimulation to see if it reduces jaw and facial pain and improves chewing and jaw movement for people with ALS or PLS.
-
Improving nutritional status and frailty in patients with motor neuron disease using silkworm pupa powder
This study is testing if adding silkworm pupa powder to the diets of people with motor neuron disease, like ALS, can help improve their nutrition, muscle strength, and overall health.
-
Early detection of respiratory impairment in ALS using breathing, MRI, and blood markers
This study tests whether breathing patterns, MRI changes in the brainstem and spinal cord, and blood markers can reveal early ALS signs, especially in people with genetic risk or early symptoms.
-
Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases
This study collects blood and genetic samples from people with neurodegenerative diseases and their families to build a shared resource for studying disease risk and biology.
-
Plasmapheresis for ALS with anti-NRIP autoantibody
This study tests whether a few plasmapheresis sessions can help people with ALS who have anti-NRIP autoantibody by keeping the antibody levels low.
-
Implanted brain interface to let people with severe paralysis control assistive devices
It will try an implanted brain interface that records and stimulates brain signals so adults with severe paralysis can control assistive devices and receive sensory feedback.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.